411
Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France
Condition(s):AsthmaLast Updated:December 29, 2011Completed
Lysine: 425 Clinical Trials, Page 42 of 43
Hide Studies Not Open or Pending
412
National Survey on Hypertension
Condition(s):HypertensionLast Updated:July 21, 2009Completed
413
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
Condition(s):Alzheimer DiseaseLast Updated:June 10, 2016Terminated
414
Yan Nian Jiu Zhuan Fa Improve Chronic Fatigue Syndromes
Condition(s):Chronic Fatigue SyndromesLast Updated:March 17, 2021Unknown status
415
S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Condition(s):Lung CancerLast Updated:November 25, 2013Completed
416
Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism With Severe Injurious Behavior.
Condition(s):Autism Spectrum DisorderLast Updated:May 24, 2017Completed
417
A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
Condition(s):Memory Disorders, Age-Related; Retention Disorders, CognitiveLast Updated:January 15, 2019Completed
418
Ketone Supplementation, Glucose Control, and Cardiovascular Function
Condition(s):Hyperglycemia, Postprandial; Overweight and Obesity; Diabetes Mellitus RiskLast Updated:April 28, 2021Completed
419
Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant
Condition(s):Diffuse Hemispheric Glioma, H3 G34-MutantLast Updated:February 2, 2023Not yet recruiting
420
Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Condition(s):Anatomic Stage IV Breast Cancer AJCC v8; Invasive Breast Carcinoma; Metastatic Triple-Negative Breast CarcinomaLast Updated:April 26, 2023Recruiting